Q1 2026 Earnings Release Presentation

‌1Q 2026 FINANCIAL RESULTS

April 30, 2026

‌Strategic execution for resilient and profitable growth

• #1 position among private companies;
  • Private Pension AuM: 19.4% m.s.
  • Total Life & PA GWP: 12.5% m.s.
• Profitable growth across all business lines…
• Robust net profit growth (Management Reporting: 52%, SFRS: 57%)
• Industry-leading RoE of 67%
• Capital-efficient with 198% solvency, supporting growth and dividends
• 1,250m TL Dividend payment
• Investment in health business via 100% subsidiary (Medisa) (2025:650m TL, Total: 1.4b TL) Strengthened fundamentals…
• Strong and exclusive bancassurance partnership with Akbank

• Scaling productivity and enhancing product mix across DSF

• Diversified Product Portfolio with RoP, Savings and Health Products

• Investments on digital analytics and customer capabilities

• Synergies with Aksigorta and Medisa across growth and efficiency
• Regulatory tailwinds for the growth of both pension and life business
• Strong shareholder structure blending local and international expertise Future…

• E2E digital transformation focused on new tech. and data analytics

• Deepen collaboration with Akbank and our insurance group
• Sustainability at the heart of business to build a better future
• Future-proof organization and an advanced workforce

Şirkete Özel

Management Reporting: IFRS Financials excluding inflation accounting effect 2

‌Strong growth driven by diversified portfolio and unique distribution model

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

robust growth with new participants and returns

Pension AuM, Total

(TL bn)

strong growth in terms of GWP with strong and diversified products

GWP, Total

(TL mn)

increased focus on pension, steady increase in # of customers

Customer exc. Credit Linked, #

(mn)

CAGR 22-25:

74%

YoY 3M26: 69%

CAGR 22-25:

87%

YoY 3M26: 50%

CAGR 22-25:

7%

YoY 3M26: 9%

Şirkete Özel

Management Reporting: IFRS Financials excluding inflation accounting effect. 3

Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.

‌Robust profitability fueled by solid and sustainable core business performance

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

CAGR 22-25:

82%

IFRS Net Profit

(Management Reporting, TL mn)

YoY 3M26: 52%

CAGR 22-25:

81%

Local Net Profit

(TL mn)

YoY 3M26: 57%

*Exc. One off-tax regulation change with regards to inflation accounting

Şirkete Özel

Management Reporting: IFRS Financials excluding inflation accounting effect.

Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation. 4

‌Resilient net technical profitability with balanced product mix

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

Technical Profit

(TL mn)

G&A, Expense Ratio

(TL mn, %)

Net Technical Profit

(TL mn)

CAGR 22-25:

88%

YoY 3M26: 53%

CAGR 22-25:

76%

YoY 3M26: 43%

CAGR 22-25:

104%

YoY 3M26: 64%

Şirkete Özel

Expense ratio=(G&A)/(Management Reporting Proft Before Tax-G&A) Management Reporting: IFRS Financials excluding inflation accounting effect.

Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation. 5

‌Strategic product mix driving scalable profitability

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

Pension Technical Profit

(TL mn)

Credit Life Technical Profit

(TL mn)

RoP & Savings Technical Profit

(TL mn)

CAGR 22-25:

93%

YoY 3M26: 53%

CAGR 22-25:

113%

YoY 3M26:

44%

CAGR 22-25:

64%

YoY 3M26:

70%

Şirkete Özel

6

Management Reporting: IFRS Financials excluding inflation accounting effect.

Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.

‌Pension

Sustainable growth and scaling ambitions

Pensions AuM including State Contribution

(TL mn)

Private Pension Fund Mix

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

CAGR 22-25:

74%

72,758

75,640

141,528

136,681

228,335

220,328

YoY 3M26:

69%

401,782 441,603

390,191 429,124

2022 2023 2024 2025 3M 26

CAGR 22-25:

10%

Number of Participants

('000)

YoY 3M26: 6%

Market Share Of AgeSA %

1,910

1,696

2,103 2,238 2,252

981

1,075

1,127

1,155

1,145

716 834

976

1,083

1,107

2022 2023 2024 2025 3M 26

Şirkete Özel

7

Management Reporting: IFRS Financials excluding inflation accounting effect. Market Data Source: EGM

‌Life

Sustainable growth fueled by multi-distribution channel model

Credit Linked GWP

(TL mn)

RoP&Savings B/S Asset Volume

(USD mn)

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

CAGR 22-25:

107%

YoY 3M26: 51%

2,455 3,699

CAGR 22-25:

29%

144

YoY 3M26: 27%

140

2022 2023 2024 2025 3M 25 3M 26

2022 2023 2024 2025 3M 25 3M 26

CAGR 22-25:

71%

RoP&Savings GWP

(TL mn)

YoY 3M26: 49%

Market Share of Agesa %, GWP

Increase in Credit Life Market Share by 5.8 pp since 2021 year-end

2022 2023 2024 2025 3M 25 3M 26

Şirkete Özel

Management Reporting: IFRS Financials excluding inflation accounting effect. 8

‌Operating leverage driving scalable and profitable growth

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

Technical Profit & G&A

(TL mn)

Expense Ratio

(%)

45.4% 47.0%

42.7% 39.2%

CAGR 22-25:

88%

CAGR 22-25:

76%

YoY 3M26:

53%

YoY 3M26:

43%

2022 2023 2024 2025 3M 26

Expense ratio=(Opex)/(Management Reporting Proft Before Tax-Opex)

Breakdown of G&A Management Reporting

3M 26

2022 2023 2024 2025 3M 25 3M 26

Technical Profit G&A

Şirkete Özel

Management Reporting: IFRS Financials excluding inflation accounting effect.

Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation. 9

‌Optimizing returns with prudent risk management

Investment and Other Income (TL mn) Shareholders' Asset Portfolio

3M 26

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

CAGR 22-25:

75%

YoY 3M26:

33%

Total: 13,229mTL

Derived from IFRS. differs from PL "Total Investment Income & Other" line excluding financial and other expenses Other income not shown; included in total.

Şirkete Özel

Management Reporting: IFRS Financials excluding inflation accounting effect.

Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.

Managed by both Agesa and Ak Asset Management

10

‌Robust capital management and efficient capital allocation

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

Shareholders' Equity & RoE

(TL mn, %)

Solvency

(%)

Dividend payment

(TL mn)

CAGR 22-25:

78%

YoY 3M26:

77%

YoY 3M26: 25%

Şirkete Özel

11

Management Reporting: IFRS Financials excluding inflation accounting effect.

Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.

‌Summary P&L from Segmental Reporting1

CAGR Inf. 22-25: 58%

YoY Inf. 3M26: 31%

64%

52%

Expenses

Net Investment Income & Other 692 915

32%

2,107

2,157

Profit Before Taxes 1,974 3,023

Taxes -556 -864

53%

55%

Management Reporting Profit for the Period

1,419 2,157

52%

*Exc. One off-tax regulation change with regards to inflation accounting

SFRS Profit for the Period 1,145 1,800 57%

Şirkete Özel

Note: (1) Management Reporting: IFRS Financials excluding inflation accounting effect. unaudited results 12

‌Solvency II

Value of New Business

‌Diversified business model supporting value growth

SII VNB figures are calculated using Best Estimate Liabilities, including a Risk Margin, and also showing the effect of real-world yields (taken as RFR +2%). Total VNB has grown by 31% due to impressive Credit Life sales growth and also the contribution of the Pension and ROP product lines.

Credit Life VNB growth was due to the higher sales volumes and higher margins after re-pricing in Q1 2026. ROP and Pension margins were limited due to assumption changes and changes to the portfolio mix.

Şirkete Özel

Note: Results based on unit expense assumptions. Total acquisition expenses above/below the modeled expense level are not taken into account. 14

Source: Company data, unaudited results * Including Channel Expenses Gross of Tax ** Including Channel & HO expenses Net of Tax

‌Disclaimer

The information in this presentation has been prepared by AgeSA Hayat ve Emeklilik A.Ş. (the "Company") solely for use at a presentation concerning the Company, its proposed lis ting on the Borsa İstanbul.

This presentation does not constitute or form part of, and should not be construed as, an offer to sell, or the solicitation or invitation of any offer to buy or subscribe for, or otherwis e acquire, any securities of the Company or an inducement to enter into investment activity. No part of this presentation, nor the fact of its distribution, should form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever.

This presentation is the sole responsibility of the Company. The information contained in this presentation does not purport to be comprehensive and has not been independently verified. The information contained herein is for discussion purposes only and does not purport to contain all information that may be required to evaluate the Company and/or its business, financial position or future performance. The information and opinions contained in this document are provided only as at the date of the presentation and are subject to change without notice. No representation, warranty or undertaking, expressed or implied, is or will be made by the Company and Ak Yatırım Menkul Değerler A.Ş. ("Ak Yatırım") or their respective affiliates, advisors or representatives or any other person as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctnes s of the information or the opinions contained in this presentation (or whether any information has been omitted from this presentation). The Company, to the extent permitted by law, and Ak Yatırım and its or their respective directors, officers , employees, affiliates, advisors or representatives disclaims all liability whatsoever (in negligence or otherwis e) for any loss however arising, directly or indirectly, from any use of this presentation or its contents or otherwis e aris ing in connection with this presentation.

To the extent available, the industry, market and competitive position data that may be provided in this presentation come from official or third party sources. Third party industry publications, studies and surveys generally state that the data contained therein have been obtained from sources believed to be reliable, but that there is no guarantee of the accuracy or completeness of such data. While the Company believes that each of these publications, studies and surveys has been prepared by a reputable source, the Company has not independently verified the data contained therein. In addition, certain of the industry, market and competitive position data contained in this presentation come from the Company's own internal research and estimates based on the knowledge and experience of the Company's management in the markets in which the Company operates. While the Company believes that such research and estimates are reasonable and reliable, they, and their underlying methodology and assumptions, have not been verified by any independent source for accuracy or completeness and are subject to change without notice. Accordingly, undue reliance should not be placed on any of the industry, market or competitive position data contained in this presentation.

This presentation and any materials distributed in connection with this presentation are not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other juris diction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such juris diction..

The offer and distribution of this presentation and other information may be restricted by law and persons into whose possession this presentation or any document or other information referred to herein comes should inform themselves about and observe any such restrictions . Any failure to comply with these restrictions may constitute a violation of the securities laws of any such juris diction.

Nothing in this presentation constitutes investment advice and any recommendations that may be contained herein have not been based upon a consideration of the investment objectives, financial situation or particular needs of any specific recipient. Investors should not rely on or act upon this presentation or any of its contents and must return it immediately to the Company.

This presentation includes "forward-looking statements". These statements contain the words "anticipate", "will", "believe", "intend", "estimate", "expect" and words of s imilar meaning. All statements other than statements of historical fact included in this presentation, including, without limitation, those regarding the Company's financial position, prospects, growth, business strategy, plans and objectives of management for future operations (including statements relating to new routes, number of aircraft, availability of financing, customer offerings , passenger and utilization statistics and objectives relating to the Company's products and services) are forward-looking statements. Such forward-looking statements involve known and unknown ris ks, uncertainties and other important factors, that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this presentation. The Company cautions you that forward-looking statements are not guarantees of future performance and that its actual financial position, prospects, growth, business strategy, plans and objectives of management for future operations may differ materially from those made in or suggested by the forward-looking statements contained in this presentation. In addition, even if the Company's financial position, prospects, growth, business strategy, plans and objectives of management for future operations are consistent with the forward-looking statements contained in this presentation, those results or developments may not be indicative of results or developments in any future period. The Company does not undertake and expressly disclaims any obligation to review or confirm or to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any events that occur or conditions or circumstances that arise after the date of this presentation.

By attending this presentation or by reading the presentation s lides, you agree to be bound by the foregoing limitations and restrictions and, in particular, will be deemed to have represented, warranted and undertaken that: (i) you have read and agree to comply with the contents of this disclaimer including, without limitation, the obligation to keep this presentation and its contents confidential; (ii) you will be solely responsible for your own assessment of the Company and its business, financial position and future performance.

Şirkete Özel

15

‌Thank you

Şirkete Özel